Its also important to note that for patients using Wegovy to reduce heart attack and stroke risk which Australias Therapeutic Goods Administration recently approved it for theres no evidence that cardiovascular benefits will be achieved at lower-than-recommended doses
The reason is physiological, not arbitrary
This removes the financial hesitation that often keeps patients at suboptimal doses and makes long-term, sustainable weight loss more accessible
Clinically, the treatment strategies during phase I utilize conventional methods: patients should be treated with hypothermia, free radical scavengers (e.g., melatonin, erythropoietin, coenzyme Q10), excitatory amino acid receptor blocking agents, and/or neuroprotective agents
Week 1-2: Appetite Changes and Early Adjustments One of the earliest changes many notice after starting Semaglutide for weight loss is decreased appetite
Half-life means the time it takes for half the drug to leave your system